Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    18722008 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety and Efficacy of PTC124 for Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Drug: PTC124
2 Not yet recruiting Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutation in Familial Adenomatous Polyposis-minors' Adjusted Version
Condition: FAP-Familial Adenomatous Polyposis
Intervention: Drug: Erythromycin

Indicates status has not been verified in more than two years